Expression of the mammalian target of Rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma

Hyunsoo Kim, Gou Young Kim, Sung Jig Lim, Youn Wha Kim

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: We investigated whether the expression of mammalian target of rapamycin (mTOR) pathway components is associated with clinicopathologic characteristics and patient outcome in lung adenocarcinoma (AC) and squamous cell carcinoma (SCC). Methods: We used immunohistochemistry to evaluate the expression of phosphorylated Akt (pAkt), mTOR, p70 ribosomal protein S6 kinase (p70S6K) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in 91 cases of AC and 154 cases of SCC. Results: pAkt expression was positively correlated with the expression of mTOR (p < 0.001) and p70S6K (p < 0.001), and mTOR expression was positively correlated with p70S6K expression (p < 0.001). PTEN expression was inversely correlated with the expression of pAkt (p = 0.001), mTOR (p < 0.001) and p70S6K (p = 0.012). In addition, loss of PTEN expression, observed in 37.4% (34/91) of AC patients, was significantly associated with a higher histologic grade (p = 0.013), pathologic T stage (p = 0.016) and N stage (p < 0.001) and advanced TNM stage (p = 0.001), as well as a shorter overall survival of AC patients (p = 0.015). Conclusion: The high prevalence of PTEN loss and its association with aggressive tumor behavior and poor patient outcome in AC suggest that loss of PTEN expression is involved in AC progression and serves as a prognostic marker for patients with AC.

Original languageEnglish
Pages (from-to)84-93
Number of pages10
JournalPathobiology
Volume79
Issue number2
DOIs
Publication statusPublished - 2012 Feb 1

Fingerprint

Sirolimus
Ribosomal Protein S6 Kinases
Squamous Cell Carcinoma
Adenocarcinoma
Chromosomes, Human, Pair 10
Phosphoprotein Phosphatases
Adenocarcinoma of lung
Immunohistochemistry
Survival
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Kim, Hyunsoo ; Kim, Gou Young ; Lim, Sung Jig ; Kim, Youn Wha. / Expression of the mammalian target of Rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma. In: Pathobiology. 2012 ; Vol. 79, No. 2. pp. 84-93.
@article{8ad335f40a6549158cbadda4324bda69,
title = "Expression of the mammalian target of Rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma",
abstract = "Objective: We investigated whether the expression of mammalian target of rapamycin (mTOR) pathway components is associated with clinicopathologic characteristics and patient outcome in lung adenocarcinoma (AC) and squamous cell carcinoma (SCC). Methods: We used immunohistochemistry to evaluate the expression of phosphorylated Akt (pAkt), mTOR, p70 ribosomal protein S6 kinase (p70S6K) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in 91 cases of AC and 154 cases of SCC. Results: pAkt expression was positively correlated with the expression of mTOR (p < 0.001) and p70S6K (p < 0.001), and mTOR expression was positively correlated with p70S6K expression (p < 0.001). PTEN expression was inversely correlated with the expression of pAkt (p = 0.001), mTOR (p < 0.001) and p70S6K (p = 0.012). In addition, loss of PTEN expression, observed in 37.4{\%} (34/91) of AC patients, was significantly associated with a higher histologic grade (p = 0.013), pathologic T stage (p = 0.016) and N stage (p < 0.001) and advanced TNM stage (p = 0.001), as well as a shorter overall survival of AC patients (p = 0.015). Conclusion: The high prevalence of PTEN loss and its association with aggressive tumor behavior and poor patient outcome in AC suggest that loss of PTEN expression is involved in AC progression and serves as a prognostic marker for patients with AC.",
author = "Hyunsoo Kim and Kim, {Gou Young} and Lim, {Sung Jig} and Kim, {Youn Wha}",
year = "2012",
month = "2",
day = "1",
doi = "10.1159/000334340",
language = "English",
volume = "79",
pages = "84--93",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "2",

}

Expression of the mammalian target of Rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma. / Kim, Hyunsoo; Kim, Gou Young; Lim, Sung Jig; Kim, Youn Wha.

In: Pathobiology, Vol. 79, No. 2, 01.02.2012, p. 84-93.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of the mammalian target of Rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma

AU - Kim, Hyunsoo

AU - Kim, Gou Young

AU - Lim, Sung Jig

AU - Kim, Youn Wha

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Objective: We investigated whether the expression of mammalian target of rapamycin (mTOR) pathway components is associated with clinicopathologic characteristics and patient outcome in lung adenocarcinoma (AC) and squamous cell carcinoma (SCC). Methods: We used immunohistochemistry to evaluate the expression of phosphorylated Akt (pAkt), mTOR, p70 ribosomal protein S6 kinase (p70S6K) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in 91 cases of AC and 154 cases of SCC. Results: pAkt expression was positively correlated with the expression of mTOR (p < 0.001) and p70S6K (p < 0.001), and mTOR expression was positively correlated with p70S6K expression (p < 0.001). PTEN expression was inversely correlated with the expression of pAkt (p = 0.001), mTOR (p < 0.001) and p70S6K (p = 0.012). In addition, loss of PTEN expression, observed in 37.4% (34/91) of AC patients, was significantly associated with a higher histologic grade (p = 0.013), pathologic T stage (p = 0.016) and N stage (p < 0.001) and advanced TNM stage (p = 0.001), as well as a shorter overall survival of AC patients (p = 0.015). Conclusion: The high prevalence of PTEN loss and its association with aggressive tumor behavior and poor patient outcome in AC suggest that loss of PTEN expression is involved in AC progression and serves as a prognostic marker for patients with AC.

AB - Objective: We investigated whether the expression of mammalian target of rapamycin (mTOR) pathway components is associated with clinicopathologic characteristics and patient outcome in lung adenocarcinoma (AC) and squamous cell carcinoma (SCC). Methods: We used immunohistochemistry to evaluate the expression of phosphorylated Akt (pAkt), mTOR, p70 ribosomal protein S6 kinase (p70S6K) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in 91 cases of AC and 154 cases of SCC. Results: pAkt expression was positively correlated with the expression of mTOR (p < 0.001) and p70S6K (p < 0.001), and mTOR expression was positively correlated with p70S6K expression (p < 0.001). PTEN expression was inversely correlated with the expression of pAkt (p = 0.001), mTOR (p < 0.001) and p70S6K (p = 0.012). In addition, loss of PTEN expression, observed in 37.4% (34/91) of AC patients, was significantly associated with a higher histologic grade (p = 0.013), pathologic T stage (p = 0.016) and N stage (p < 0.001) and advanced TNM stage (p = 0.001), as well as a shorter overall survival of AC patients (p = 0.015). Conclusion: The high prevalence of PTEN loss and its association with aggressive tumor behavior and poor patient outcome in AC suggest that loss of PTEN expression is involved in AC progression and serves as a prognostic marker for patients with AC.

UR - http://www.scopus.com/inward/record.url?scp=84862804733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862804733&partnerID=8YFLogxK

U2 - 10.1159/000334340

DO - 10.1159/000334340

M3 - Article

VL - 79

SP - 84

EP - 93

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 2

ER -